Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GHRS compared with MLTX: revenue, margins and what each company keeps, and the suppliers and customers both name
GHRS
GH Research PLC
Change
Mkt cap
Revenue
Revenue
MLTX
MoonLake Immunotherapeutics
Change
Mkt cap
Revenue
Revenue
vs
Compare
GHRS
GH Research PLC
vs
MLTX
MoonLake Immunotherapeutics
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
GHRS
No earnings history for GHRS.
MLTX
2 of 4 reports
0 of 2
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±14.2%
▼
−1.20%
×0.08
Q2 FY26
±23.0%
▼
−5.09%
×0.22
= implied
GHRS realized, solid
MLTX realized, hatched
One scale, both sides: full bar = 24%
× = |realized| ÷ implied
Source: market data
GHRS
GH Research PLC
Change
18.56
▲
+0.65%
· post 18.56
Mkt cap
$1.2B
MLTX
MoonLake Immunotherapeutics
Change
11.53
▲
+6.76%
· post 11.57
Closed
Nov 6 '26
Mkt cap
$981.3M
vs
Compare
Closed
Nov 6 '26
GHRS
GH Research PLC
vs
MLTX
MoonLake Immunotherapeutics
18.56
▲
+0.65%
post 18.56
Price
11.53
▲
+6.76%
post 11.57
$1.2B
Mkt cap
$981.3M
Change
Change
GHRS
18.56
▲
+0.65%
vs
MLTX
11.53
▲
+6.76%
Closed
Nov 6 '26